C10 Labs, L.P. — Form D/A
C10 Labs, L.P. of CAMBRIDGE, MA, a pooled investment fund, filed a Form D amendment with the SEC on 2024-06-27. The offering totals $77.9M, of which $77.9M was reported sold. Industry: Pooled Investment Fund.
Offering
- Filed: 2024-06-27
- Form: D/A
- Accession: 0001980312-24-000004
- Industry: Pooled Investment Fund
- Exemptions: 06b, 3C, 3C.1
- Total offering: $77.9M
- Amount sold: $77.9M
- Investors: 18
- Date of first sale: 2023-06-28
- Security types: fund interests
- Revenue range: Not Applicable
- SEC file number: 021-484976
Issuer
- Name: C10 Labs, L.P.
- CIK: 0001980312
- Entity type: Limited Partnership
- Jurisdiction: DELAWARE
- Incorporated: 2023
- Address: 245 MAIN STREET, FLOOR 2, CAMBRIDGE, MA, 02142
- Phone: 617-710-1792
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| Shahid Azim | Executive Officer | Cambridge, MA |
| N/A C10 Labs GP, LLC | Executive Officer | Cambridge, MA |
| Patricia Geli | Executive Officer | Cambridge, MA |
| Ramesh Raskar | Executive Officer | Cambridge, MA |
| N/A Studio 2139 GP, LLC | Executive Officer | Cambridge, MA |
Other filings by this issuer (1)
More